BELLEVUE GROUP AG – CRISPR Therapeutics AG Transaction History
BELLEVUE GROUP AG portfolio value:
$60.66M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.68% | 6.3K shares | 4.63M | $65.35 | 928.30K |
| Q2 2022 | share | Decrease | -0.53% | -4.9K shares | -2.15M | $60.77 | 922.00K |
| Q1 2022 | share | Decrease | -4.90% | -47.77K shares | -15.67M | $62.77 | 926.90K |
| Q4 2021 | share | 0.00% | 0 shares | -35.23M | $78.85 | 974.68K | |
| Q3 2021 | share | Increase | +0.81% | 7.8K shares | -47.43M | $111.93 | 974.68K |
| Q2 2021 | share | Decrease | -1.18% | -11.5K shares | 37.31M | $161.89 | 966.88K |
| Q1 2021 | share | Increase | +7.55% | 68.7K shares | -20.06M | $121.85 | 978.38K |
| Q4 2020 | share | Decrease | -4.17% | -39.57K shares | 59.88M | $153.11 | 909.68K |
| Q3 2020 | share | Increase | +18.59% | 148.8K shares | 20.57M | $83.64 | 949.26K |
| Q2 2020 | share | 0.00% | 0 shares | 24.87M | $73.49 | 800.46K | |
| Q1 2020 | share | Increase | +9.58% | 70K shares | -10.54M | $42.41 | 800.46K |
| Q4 2019 | share | Decrease | -12.75% | -106.7K shares | 10.17M | $60.91 | 730.46K |
| Q3 2019 | share | Increase | +3.29% | 26.7K shares | -3.85M | $40.99 | 837.16K |
| Q2 2019 | share | Increase | 0.00% | 810.46K shares | 38.17M | $47.1 | 810.46K |